 |
diannexin |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of ischemia-reperfusion injury in solid organ transplants |
| USA Market Approval | USA |
| USA Designation Date | 2009-10-28 00:00:00 |
| Sponsor | Astellas Pharma Global Development, Inc.;Three Parkway North;Deerfield, Illinois, 60015 |
